Join us on March 16th from 1:00pm – 2:00pm ET for a webinar titled, “Pharmacokinetics 101: Introducing PK Concepts & NCA.” Nuventra’s Vice President of Clinical Pharmacology & Pharmacokinetics, Mark Bush, Ph.D., provides an overview of Pharmacokinetics (PK) and Noncompartmental Analysis (NCA) fundamentals. This will be a replay of our PK 101 webinar with a live Q&A session following the presentation.
PK analysis, including NCA, helps to characterize how a drug enters, distributes, and is removed from the body. PK data contribute to much of what is included in a drug label. This information can be applied to help us understand key aspects of a drug (e.g., optimal dosing regimen, drug interactions, and sources of variability in safety or efficacy) and can guide decision-making throughout the drug development process.
At the end of this webinar, attendees should have a better understanding of:
- PK and NCA fundamentals
- Routes of administration
- Key NCA parameters
- Areas under the curve
- PK parameters derived from AUC
This webinar is free of charge.
Meet the Presenter
Mark A. Bush, Ph.D.
Vice President, Clinical Pharmacology & Pharmacokinetics
Dr. Bush has over 20 years of experience in Clinical Pharmacology and Pharmacokinetics with a particular focus in clinical pharmacology study design and interpretation. His therapeutic concentrations include Endocrinology and Metabolism in early phases of development. Dr. Bush has worked on over 100 PK and Population PK analyses.